3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
8
Gastrointestinal
8
Head & Neck
7
Dermatologic
3
Gynecologic
2
Genitourinary
2
Breast
2
Sarcoma
1
Conditions
Sarcoma
317
Gastrointestinal Stromal Tumors
108
Neoplasms
105
Breast Neoplasms
92
Melanoma
81
Ovarian Neoplasms
79
Neoplasm Metastasis
74
Carcinoma, Non-Small-Cell Lung
74
Colorectal Neoplasms
70
Osteosarcoma
61
Stomach Neoplasms
59
Pancreatic Neoplasms
55
Bone Neoplasms
55
Prostatic Neoplasms
51
Head and Neck Neoplasms
48
Glioblastoma
48
Sarcoma, Ewing
47
Lung Neoplasms
45
Esophageal Neoplasms
42
Squamous Cell Carcinoma of Head and Neck
41
Carcinoma, Renal Cell
40
Uterine Cervical Neoplasms
39
Sarcoma, Kaposi
38
Lymphoma
37
Urinary Bladder Neoplasms
36
Sarcoma, Synovial
36
Recurrence
35
Dendritic Cell Sarcoma, Interdigitating
34
Lymphoma, Non-Hodgkin
33
Endometrial Neoplasms
33
Interventions
pembrolizumab
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Noonan Syndrome
×
Sarcoma
×
Clear all
NCT04670679
2026-03-25
FLAGSHP-1
Erasca, Inc.
Phase 1
Active not recruiting
90 enrolled